Status:
UNKNOWN
Efficacy of Navigable Percutaneous Plasma Disc Decompression Device (L'DISQ) in Patients With Severe Lumbar Disc Herniation
Lead Sponsor:
Korea University Anam Hospital
Conditions:
Lumbar Disc Herniation
Eligibility:
All Genders
Brief Summary
This study aims to assess the clinical outcome of percutaneous disc decompression using the L'DISQ in patients with severe lumbar disc herniation (LDH).
Detailed Description
Low back pain (LBP) is one of the most leading cause of chronic pain worldwide and 70-85% of adults have experienced LBP during their lifetime. The one of most common symptom of lumbar disc herniation...
Eligibility Criteria
Inclusion
- single-level LDH of MSU classification of grade 3 and refusal of spine surgery
- LBP or lower extremity pain symptoms that persisted for 3 months or more
- unresponsiveness to sufficient conservative treatments, including oral analgesics, physical modalities, or spinal injections (such as selective nerve root blocks)
- limited activities of daily living due to pain.
Exclusion
- patients lost during the 1-year follow-up
- evidence of peripheral neuropathy on electromyography, which might cause lower extremity pain
- evidence of vertebral fracture in the X-ray analysis
- history of tumor or myelopathy
- history of spinal surgery
- history of coagulopathy
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05231759
Start Date
March 1 2009
End Date
March 31 2022
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.